Immunohistochemical evidence of BMP-2, -4 and -7 activity in otospongiosis

Acta Oto-Laryngologica

Volumn 128, Issue 1, 2008, Pages 13-17

  Lehnerdt, Goetz ^a   Unkel, Claus ^a   Metz, Klaus Alfred ^a   Jahnke, Klaus ^a   Neumann, Andreas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

BMP; Bone morphogenetic protein; Immunohistochemistry; Otosclerosis; Otospongiosis

Indexed keywords

ALKALINE PHOSPHATASE; AVIDIN; BIOTIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN G ANTIBODY; OSTEOGENIC PROTEIN 1; PEROXIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; OSTEOBLAST; OSTEOCLAST; OTOSCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPEDECTOMY; STAPES; TISSUE GROWTH; TISSUE REPAIR;

ADULT; BONE MARROW; BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OTOSCLEROSIS; REFERENCE VALUES; STAPES; STAPES SURGERY; TRANSFORMING GROWTH FACTOR BETA;

EID: 37549058040     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701299659     Document Type: Article

References (16)

1. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001;22:249-57.
2. Frisch T, Sorensen MS, Overgaard S, Bretlau P. Estimation of volume referent turnover in the otic capsule after sequential point labelling. Ann Otol Rhinol Laryngol 2000;109:33-9.
3. Declau F, van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, et al. Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol 2001;22:596-602.
4. Gordon MA. The genetics of otosclerosis: a review. Am J Otol 1989;10:426-38.
5. Gros A, Vatovec J, Sereg-Bahar M. Histologic changes on stapedial footplate in otosclerosis. Otol Neurotol 2003;24:43-7.
6. Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, et al. BMP signalling components are expressed in human fracture callus. Bone 2003;33:362-71.
7. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999;25:91-3.
8. Yu Y, Yang JL, Chapman-Sheath PJ, Walsh WR. TGF-beta, BMPS and their signal transducing mediators (Smads) in rat fracture healing. J Biomed Mater Res 2002;60:392-7.
9. Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through Smad proteins. Nature 1997;390:465-71.
10. Yamashita H, Ten Dijke P, Heldin CH, Miyazono K. Bone morphogenetic protein receptors. Bone 1996;19:596-74.
11. Guerkov HH, Lohmann CH, Liu Y, Dean DD, Simon BJ, Heckman JD, et al. Pulsed electromagnetic fields increase growth factor release by non-union cells. Clin Orthop 2001;(384):265-79.
12. Liu W, Oh SH, Kang Yk Y, Li G, Doan TM, Little M, et al. Bone morphogenetic protein 4 (BMP4): a regulator of capsule chondrogenesis in the developing mouse inner ear. Dev Dyn 2003;226:427-38.
13. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. Evidence from normal bone expression and targeted mis-expression that bone morphogenetic protein (Bmp-4) plays a role in a mouse embryonic lung morphogenesis. Development 1996;122:1693-702.
14. Hardwick JHC, van den Brink GR, Bleuming SA, Ballester I, van den Brande JM, Keller JJ, et al. Bone morphogenetic protein 2 is expressed by and acts upon mature epithelial cells in the colon. Gastroenterology 2004;126:111-21.
15. Kloen P, Doty SB, Gordon E, Rubel IF, Goumans MJ, Helfet DL. Expression and activation of the BMP-signalling components in human fracture non-unions. J Bone Joint Surg Am 2002;84-A:1909-18.
16. Sudhoff H, Linthicum FH Jr. Temporal bone fracture and latent meningitis: temporal bone histopathology study of the month. Otol Neurotol 2003;24:521-2.